1
|
Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases. Environ Health Prev Med 2009; 14:216-22. [PMID: 19568841 DOI: 10.1007/s12199-008-0063-8] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2008] [Accepted: 10/19/2008] [Indexed: 01/05/2023] Open
Abstract
This review is partly composed of the presentation "Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases" delivered during the symposium "Biological effects of fibrous and particulate substances and related areas" organized by the Study Group of Fibrous and Particulate Studies of the Japanese Society of Hygiene and held at the 78th Annual Meeting in Kumamoto, Japan. In this review, we briefly introduce the results of recent immunological analysis using the plasma of silica and asbestos-exposed patients diagnosed with silicosis, pleural plaque, or malignant mesothelioma. Thereafter, experimental background and speculation concerning the immunological pathophysiology of silica and asbestos-exposed patients are discussed.
Collapse
|
2
|
Hayashi H, Maeda M, Murakami S, Kumagai N, Chen Y, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Yoshida Y, Nishimura Y, Kusaka M, Fujimoto W, Otsuki T. Soluble Interleukin-2 Receptor as an Indicator of Immunological Disturbance Found in Silicosis Patients. Int J Immunopathol Pharmacol 2009; 22:53-62. [DOI: 10.1177/039463200902200107] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Silicosis patients (SILs) possess not only respiratory disorders but also alterations in autoimmunity. To determine an early indicator of immunological disturbance in SILs, the role of serum-soluble interleukin (IL)-2 receptor (sIL-2R) was analyzed. Of ten SILs, immunological clinical parameters such as immunoglobulin (Ig) G, complements, the titer of autoantibodies including anti-nuclear antibodies (ANA), anti-Scl-70 antibody (Ab) and anti-centromere (CM) Ab, and experimental indicators such as serum-soluble Fas, serum IL-2, CD25+ cells in CD4+ or CD8+ fractions, and sIL-2R were divided from respiratory parameters such as % vital capacity (%VC), percentage of forced expiratory volume in 1 second (FEV1.0%) and v25/Ht (liter/second/m(body height) by a correlation assay. Additionally, a stepwise regression test showed that sIL-2R was correlated with Ig G, ANA and anti-CM Ab. Furthermore, factor analysis revealed that sIL-2R contributed to the subpopulation of SILs with poorer immunological status in the absence of alterations in respiratory status. By defining healthy donors as 1, SILs as 2 and patients with systemic sclerosis as 3 for immunopathological progression status as metric variables, sIL2R and ANA showed a strong positive correlation. This suggests that sIL-2R is a good clinical indicator of immunological disturbance found in SILs without clinical manifestations of any disturbance in autoimmunity. Further analysis using a large-scale number of patients should be performed to confirm these findings.
Collapse
Affiliation(s)
- H. Hayashi
- Department of Hygiene, Kawasaki Medical School, Kurashiki
- Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan
| | - M. Maeda
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - S. Murakami
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - N. Kumagai
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - Y. Chen
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - T. Hatayama
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - M. Katoh
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - N. Miyahara
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - S. Yamamoto
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | - Y. Yoshida
- Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan
| | - Y. Nishimura
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| | | | - W. Fujimoto
- Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan
| | - T. Otsuki
- Department of Hygiene, Kawasaki Medical School, Kurashiki
| |
Collapse
|